Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Epilepsy-microcephaly-skeletal dysplasia syndrome is characterized by the association of moderate to severe intellectual deficit, microcephaly, epilepsy, coarse face, hirsutism and skeletal abnormalities (scoliosis and retarded bone development). It has been described only once, in two sibs (one male and one female). This syndrome is likely to be an autosomal recessive condition and thus parents should be informed of a 25% risk of recurrence for other children.
Biomarker and diagnostic research for epilepsy-microcephaly-skeletal dysplasia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for epilepsy-microcephaly-skeletal dysplasia syndrome.
305 publications have been identified in PubMed for epilepsy-microcephaly-skeletal dysplasia syndrome. Kisho has analyzed 53 by research type. Research spans Review / Meta-Analysis (72%), Basic Science / Preclinical (13%), and Epidemiology / Natural History (6%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 38 | 72% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
7 |
13% |
Disease patterns and progression | 3 | 6% |
Patient case studies | 2 | 4% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
Creignou M (2026). [PMID: 41651099](https://pubmed.ncbi.nlm.nih.gov/41651099/). *Semin Cancer Biol*. [Review / Meta-Analysis]
Pfirrmann C (2026). [PMID: 40998114](https://pubmed.ncbi.nlm.nih.gov/40998114/). *Orthop Traumatol Surg Res*. [Review / Meta-Analysis]
Elshimy G (2026). [PMID: 29939654](https://pubmed.ncbi.nlm.nih.gov/29939654/). *Unknown Journal*. [Basic Science / Preclinical]
Quelhas D (2026). [PMID: 41554664](https://pubmed.ncbi.nlm.nih.gov/41554664/). *J Inherit Metab Dis*. [Review / Meta-Analysis]
Valientes SDA (2026). [PMID: 41751561](https://pubmed.ncbi.nlm.nih.gov/41751561/). *Genes (Basel)*. [Case Report / Case Series]
Wong WJ (2025). [PMID: 40720765](https://pubmed.ncbi.nlm.nih.gov/40720765/). *Blood Adv*. [Basic Science / Preclinical]
Singh A (2025). [PMID: 40306028](https://pubmed.ncbi.nlm.nih.gov/40306028/). *J Autoimmun*. [Review / Meta-Analysis]
Merz AMA (2025). [PMID: 39445410](https://pubmed.ncbi.nlm.nih.gov/39445410/). *Haematologica*. [Review / Meta-Analysis]
Chang D (2025). [PMID: 40974782](https://pubmed.ncbi.nlm.nih.gov/40974782/). *Leuk Res*. [Review / Meta-Analysis]
Johnson JL (2025). [PMID: 40523242](https://pubmed.ncbi.nlm.nih.gov/40523242/). *J Am Acad Orthop Surg*. [Review / Meta-Analysis]